Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-22-006830

Options or other derivatives

  • See Remarks acquired 187,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GARDNER JASON See Remarks 2022-02-15 Grant or award · Stock Option (Right to Buy) +187,500 187,500 D
Loading xslF345X03/doc4.xml…